Literature DB >> 27957050

The New Novel Oral Anticoagulants (NOACs) In Patients With Atrial Fibrillation: Dogma, Dilemmas, And Decisions On Dosing.

James A Reiffel M D1.   

Abstract

Entities:  

Year:  2014        PMID： 27957050      PMCID： PMC4956138          DOI： 10.4022/jafib.1037

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


× No keyword cloud information.
  19 in total

1.  Letter by Reiffel regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial".

Authors:  James A Reiffel
Journal:  Circulation       Date:  2012-01-24       Impact factor: 29.690

2.  Survival benefit of new anticoagulants compared with warfarin in patients with atrial fibrillation: a meta-analysis.

Authors:  Tong Liu; Panagiotis Korantzopoulos; Lijian Li; Guangping Li
Journal:  Int J Cardiol       Date:  2012-01-16       Impact factor: 4.164

Review 3.  Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis.

Authors:  Ida Ehlers Albertsen; Lars Hvilsted Rasmussen; Thure Filskov Overvad; Tina Graungaard; Torben Bjerregaard Larsen; Gregory Y H Lip
Journal:  Stroke       Date:  2013-03-12       Impact factor: 7.914

Review 4.  Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials.

Authors:  George Ntaios; Vasileios Papavasileiou; Hans-Christoph Diener; Konstantinos Makaritsis; Patrik Michel
Journal:  Stroke       Date:  2012-11-13       Impact factor: 7.914

5.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

Review 6.  Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.

Authors:  Ariel Dogliotti; Ernesto Paolasso; Robert P Giugliano
Journal:  Clin Cardiol       Date:  2013-01-21       Impact factor: 2.882

Review 7.  Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation.

Authors:  William L Baker; Olivia J Phung
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-08-21

Review 8.  Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Authors:  Jeremy P Berman; Jonathan L Halperin
Journal:  Hosp Pract (1995)       Date:  2013-02

9.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

Review 10.  Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models.

Authors:  Brendan L Limone; William L Baker; Jeffrey Kluger; Craig I Coleman
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.